The career session offers the great opportunity to gain insight in all the different career options that a graduated PhD student can follow. Like in past years, interesting speakers from various scientific backgrounds will give a short introduction about their own career as well as their current working field and are open for further discussions. In order to cover a broad spectrum, we want to invite speakers from the pharmaceutical industry, scientific research, patent law, institutions such as EMBO or DFG and companies that provide us with technical support. We invite everyone to take part in our session!
Frankfurt a.M., Germany
Dr. Petra Arndt is an alumni of theUniversity of Würzburg (Phd in Biology) and started her career as a research scientist in R&D in pharmaceutical industry. After years of experience as a senior scientist, lab head and project leader in cardiovascular and diabetes research Dr. Arndt started her path as a freelancer in scientific consulting, quality and project management and as a trainer.
Wiebeke Ginter studied Biology at the Friedrich-Schiller-University Jena with major subjects in Genetics and minor subjects in Immunology, Pharmacology and Economics. She did an Erasmus exchange in France at the University of Montpellier. For the degree dissertation she went to the University of Oxford in England. Wiebke Ginter performed her PhD at the TWINCORE Institute for Infection Immunology in Hannover and worked at the Hannover Medical School as coordinator of the LISA and the AMIBA student program. Since 2016 Wiebke Ginter is employed at the Deutsche Forschungsgemeinschaft (DFG) as programme officer. Her scientific areas of responsibility are Nutritional Sciences, Gastroenterology, Metabolism, Endocrinology and Diabetology. In these fields, she supports researchers within different funding programmes: From early career support via individual research grants to support of coordinated programmes. She is responsible for the counselling of scientists, contact with reviewers, preparation of the decisions of the different decision-making bodies and for accompanying funded projects.
Barry Drees received his PhD in Molecular Genetics at the University of California, San Francisco. Following his postdoctoral work as a fellow of the US National Institute of Health, he worked as a medical writer in the pharmaceutical industry at Hoechst/Aventis for 12 years, setting up a Phase 1 writing group and leading several regulatory submission teams. Barry is an experienced trainer of medical writers and a frequent speaker on medical writing, statistics, and other scientific communication topics for various pharmaceutical associations. He is the former Editor-in-Chief of The Write Stuff, and was President of the European Medical Writers Association. He is currently a co-founder and Senior Partner of Trilogy Writing & Consulting, a medical writing consultancy that specializes in helping companies plan, coordinate and write clinical regulatory documentation. Trilogy’s clients include pharmaceutical companies and Clinical Research Organizations (CROs) of all sizes, worldwide.
Dr. Vanessa Quodt studied Biology at the University of Cologne and performed her PhD in Plant Genetics at the Max-Planck-Institute for Plant Breeding Research. After a brief postdoctoral project she left academia and joined Elsevier, a world-leading provider of information solutions. She has been working as a Journal Publisher since 2008, dealing with different journal portfolios in the medical field. Her most recent responsibility is the strategic development of the Integrative Medicine portfolio, consisting of 6 international scientific journals and two German language magazines.